查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1817967

2032 年生物活性玻璃市場預測：按類型、形式、技術、應用、最終用戶和地區進行的全球分析

Bioactive Glasses Market Forecasts to 2032 - Global Analysis By Type (Silicate-Based Bioactive Glasses, Borate-Based Bioactive Glasses, Phosphate-Based Bioactive Glasses, and Other Types), Form, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球生物活性玻璃市場預計在 2025 年達到 13 億美元，到 2032 年將達到 20 億美元，預測期內的複合年成長率為 6.4%。

生物活性玻璃是一種獨特的生物材料，由二氧化矽、氧化鈣、氧化鈉和五氧化二磷組成，可與生物組織結合。植入後，它會釋放離子來刺激細胞活性，促進骨再生，並形成類似天然骨礦物質的羥基碳酸鹽磷灰石層。它廣泛應用於牙科、整形外科、創傷治療等領域。其生物相容性、抗菌特性以及與生物系統的整合能力使其有別於惰性植入材料，在再生醫學應用上具有重要價值。

根據 FDA 的說法，生物活性玻璃支架被核准用作移植骨替代物，因為它們可以與活組織主動結合並促進自然骨再生。

全球老齡人口正在增加

全球人口老化正在推動生物活性玻璃的需求，尤其是在牙科、整形外科和骨再生應用領域。老年人患有骨質疏鬆症、骨折和牙齒脫落的幾率更高，這促使人們採用先進的生物材料進行組織修復和植入。生物活性玻璃以其優異的生物活性和相容性，作為傳統植入物的替代品正日益受到歡迎。這種人口結構的變化正推動全球醫療保健系統擴大採用創新生醫材料來患者照護，從而確保市場持續成長。

生物活性玻璃產品高成本

儘管生物活性玻璃產品具有強大的治療潛力，但由於高成本，市場面臨巨大限制。複雜的製造流程、昂貴的原料以及嚴格的監管要求推高了生產成本。這些成本限制了其在價格敏感型市場的供應，並阻礙了其在新興經濟體的廣泛應用。此外，當有更便宜的替代品時，醫療保健提供者可能會猶豫是否建議昂貴的生醫材料。如果沒有成本效益高的製造技術和可擴展的生產技術的進步，高昂的價格障礙可能會嚴重限制其在全球醫療保健生態系統中的廣泛市場滲透。

創新產品形式的開發

被覆劑、顆粒和注射粉等新產品形式的開發，為生物活性玻璃提供了誘人的成長機會。這些創新增強了臨床多功能性，並使其在牙科、創傷治療和整形外科實現客製化應用。奈米結構生物活性玻璃和混合複合材料的研究正在擴大治療可能性。此外，學術機構和醫療設備公司之間的合作正在加速產品商業化。透過擴展可用性和改善治療效果，創新產品形式有望在已開發和新興醫療保健市場中得到更廣泛的應用。

醫療保健領域的限制性報銷政策

缺乏優惠的報銷政策對生物活性玻璃技術的推廣構成了重大威脅。許多醫療保健系統將生物活性玻璃歸類為非必需或高階療法，導致患者自付費用高昂。這種經濟負擔限制了市場滲透，尤其是在中低收入地區。此外，有限的保險覆蓋範圍也阻礙了醫院和診所大規模採用此類先進的生物材料。除非報銷政策擴大到涵蓋生物活性解決方案，否則儘管其具有臨床有效性，其成長前景仍可能受到抑制。

COVID-19的影響：

新冠疫情擾亂了供應鏈，推遲了選擇性醫療程序，並對牙科和整形外科對生物活性玻璃的需求產生了負面影響。許多醫療系統優先考慮嚴重監護，並推遲了非緊急手術和植入治療。然而，疫情加速了再生醫學和生物材料研究的創新，為生物活性解決方案創造了新的機會。隨著選擇性手術的恢復，強勁的需求預計將推動復甦。總體而言，雖然新冠疫情帶來了短期挑戰，但也增強了生物活性玻璃在先進醫療保健領域的長期相關性。

預計矽酸鹽基生物活性玻璃市場在預測期內將佔據最大佔有率

矽酸鹽基生物活性玻璃因其成熟的臨床性能和廣泛的治療應用，預計將佔據市場主導地位。這些材料表現出優異的生物活性，可促進與骨骼和牙組織的有效結合。廣泛的研究支援、商業化產品的可用性以及在植入和塗層領域的成功應用，鞏固了該領域的領先地位。此外，良好的機械性能和易於製造的特性使矽酸鹽基玻璃成為生物醫學工程的首選。對成熟可靠的生物材料日益成長的需求，使該領域佔據市場主導地位。

預計預測期內粉末部分將以最高的複合年成長率成長。

由於粉末在微創手術和組織工程應用中的應用日益廣泛，預計其在預測期內的複合年成長率最高。粉狀生物活性玻璃用途廣泛，可增加細胞交互作用的表面積，加速癒合。它可製成注射劑型並可嵌入支架，使其在再生醫學領域極具吸引力。奈米技術的進步進一步提升了療效並促進了產品創新。隨著臨床對靈活高效生醫材料的需求不斷成長，粉末領域有望快速成長。

比最大的地區

由於醫療基礎設施的不斷擴張、醫療旅遊業的蓬勃發展以及老年人口的不斷成長，亞太地區預計將佔據最大的市場佔有率。中國、印度和日本等國家對牙科和整形外科領域先進生醫材料的需求正在不斷成長。政府支持醫療現代化的舉措以及不斷成長的可支配收入進一步刺激了這些材料的採用。此外，強大的研發實力和本地製造能力也鞏固了該地區的地位。這些因素共同確保了亞太地區成為生物活性玻璃的主要產生收入地區。

複合年成長率最高的地區：

北美預計將實現最高的複合年成長率，這與強勁的技術創新和先進生物材料的廣泛應用息息相關。該地區受益於完善的醫療基礎設施、廣泛的臨床研究以及早期的監管核准。骨科疾病和牙科疾病的高發性推動了醫院和專科診所對生物活性玻璃的需求。此外，大學、新興企業和醫療設備公司之間的策略聯盟正在加速技術創新。強大的患者意識和醫療保健支出使北美成為成長最快的區域市場。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生物活性玻璃市場類型

  • 矽酸鹽基生物活性玻璃
  • 硼酸鹽基生物活性玻璃
  • 磷酸鹽基生物活性玻璃
  • 其他類型

6. 全球生物活性玻璃市場（依形式）

  • 粉末
  • 纖維
  • 顆粒

7. 全球生物活性玻璃市場（按技術）

  • 熔體淬火
  • 溶膠-凝膠法
  • 火焰合成
  • 其他技術

8. 全球生物活性玻璃市場（依應用）

  • 骨再生
  • 牙科護理
  • 整形外科植入和塗層
  • 傷口癒合
  • 藥物輸送

9. 全球生物活性玻璃市場（依最終用戶）

  • 醫院和診所
  • 牙醫診所
  • 研究機構
  • 醫療設備製造商

第 10 章全球生物活性玻璃市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第 12 章：公司概況

  • SCHOTT AG
  • Mo-Sci Corporation
  • Noraker
  • Vitryxx AG
  • NovaBone Products LLC
  • Stryker Corporation
  • BonAlive Biomaterials Ltd
  • Zimmer Biomet Holdings Inc.
  • Corning Incorporated
  • Sinanen Zeomic Co. Ltd.
  • Arthrex Inc.
  • DePuy Synthes（Johnson & Johnson）
  • Biomet 3i LLC
  • Dentsply Sirona Inc.
  • Mitsubishi Chemical Corporation
  • Matexcel
Product Code: SMRC30930

According to Stratistics MRC, the Global Bioactive Glasses Market is accounted for $1.3 billion in 2025 and is expected to reach $2.0 billion by 2032 growing at a CAGR of 6.4% during the forecast period. Bioactive glasses are specialized biomaterials composed of silica, calcium oxide, sodium oxide, and phosphorous pentoxide that bond with living tissues. When implanted, they release ions that stimulate cellular activity, promote bone regeneration, and form a hydroxycarbonate apatite layer similar to natural bone mineral. They are widely used in dentistry, orthopedics, and wound healing. Their biocompatibility, antimicrobial properties, and ability to integrate with biological systems distinguish them from inert implant materials, making them valuable in regenerative medicine applications.

According to the FDA, bioactive glass scaffolds are approved for use in bone graft substitutes, as they actively bond with living tissue and stimulate natural bone regeneration.

Market Dynamics:

Driver:

Growing aging population globally

The global rise in the aging population is fueling demand for bioactive glasses, particularly in dental, orthopedic, and bone regeneration applications. Elderly individuals face higher incidences of osteoporosis, fractures, and tooth loss, spurring adoption of advanced biomaterials for tissue repair and implants. Bioactive glasses, with their excellent bioactivity and compatibility, are gaining traction as substitutes for traditional grafts. This demographic shift ensures sustained market growth, as healthcare systems worldwide increasingly turn to innovative biomaterials for elderly patient care.

Restraint:

High cost of bioactive glass products

Despite strong therapeutic potential, the market faces a significant restraint due to the high cost of bioactive glass products. Complex manufacturing processes, expensive raw materials, and stringent regulatory requirements elevate production expenses. These costs limit accessibility in price-sensitive markets, hindering widespread adoption in developing economies. Additionally, healthcare providers may hesitate to recommend premium biomaterials when cheaper alternatives exist. Without cost-effective manufacturing advancements and scalable production techniques, the high pricing barrier could significantly restrict broader market penetration across global healthcare ecosystems.

Opportunity:

Development of innovative product forms

The development of novel product forms such as coatings, granules, and injectable powders offers a compelling growth opportunity for bioactive glasses. These innovations enhance clinical versatility, allowing tailored applications in dentistry, wound healing, and orthopedics. Research into nano-structured bioactive glasses and hybrid composites is expanding therapeutic possibilities. Furthermore, collaborations between academic institutions and medical device companies accelerate product commercialization. By broadening usability and improving outcomes, innovative product formats are set to attract wider adoption across both advanced and emerging healthcare markets.

Threat:

Limited reimbursement policies in healthcare

The lack of favorable reimbursement frameworks poses a critical threat to the adoption of bioactive glass technologies. Many healthcare systems categorize bioactive glasses as non-essential or premium therapies, resulting in out-of-pocket costs for patients. This financial burden restricts market penetration, particularly in low- and middle-income regions. Moreover, limited insurance coverage discourages hospitals and clinics from adopting these advanced biomaterials at scale. Unless reimbursement policies expand to include bioactive solutions, growth prospects may be curtailed despite their clinical effectiveness.

Covid-19 Impact:

The COVID-19 pandemic disrupted supply chains and delayed elective medical procedures, negatively impacting demand for bioactive glasses in dentistry and orthopedics. Many healthcare systems prioritized critical care, postponing non-urgent surgeries and implant treatments. However, the pandemic also accelerated innovation in regenerative medicine and biomaterials research, opening new opportunities for bioactive solutions. As elective procedures resume, pent-up demand is expected to fuel recovery. Overall, while COVID-19 created short-term challenges, it reinforced the long-term relevance of bioactive glasses in advanced healthcare.

The silicate-based bioactive glasses segment is expected to be the largest during the forecast period

The silicate-based bioactive glasses segment is expected to dominate the market due to its well-established clinical performance and broad therapeutic applications. These materials exhibit superior bioactivity, promoting effective bonding with bone and dental tissues. Extensive research backing, availability of commercialized products, and successful use in implants and coatings strengthen this segment's leadership. Moreover, favorable mechanical properties and ease of fabrication make silicate-based glasses a preferred choice in biomedical engineering. As demand for proven and reliable biomaterials rises, this segment secures its market dominance.

The powders segment is expected to have the highest CAGR during the forecast period

The powders segment is anticipated to witness the highest CAGR during the forecast period, reinforced by its growing use in minimally invasive procedures and tissue engineering applications. Powdered bioactive glasses are versatile, offering enhanced surface area for cellular interaction and faster healing outcomes. Their adaptability in injectable forms and incorporation into scaffolds boosts appeal in regenerative medicine. Advancements in nanotechnology further enhance efficacy and product innovation. With rising clinical demand for flexible and effective biomaterials, the powders segment is poised for rapid growth.

Region with largest share:

Asia Pacific is expected to command the largest market share, ascribed to its expanding healthcare infrastructure, rising medical tourism, and growing geriatric population. Countries such as China, India, and Japan are witnessing increased demand for advanced biomaterials in dentistry and orthopedics. Government initiatives supporting healthcare modernization and rising disposable incomes further accelerate adoption. Additionally, strong R&D presence and local manufacturing capacities strengthen the region's position. Collectively, these factors ensure Asia Pacific's dominance as the leading revenue-generating region for bioactive glasses.

Region with highest CAGR:

North America is projected to record the highest CAGR, associated with strong technological innovation and robust adoption of advanced biomaterials. The region benefits from well-established healthcare infrastructure, extensive clinical research, and early regulatory approvals. High prevalence of bone-related conditions and dental disorders fuels demand for bioactive glasses in both hospitals and specialty clinics. Additionally, strategic collaborations between universities, startups, and medical device companies accelerate innovation. With strong patient awareness and healthcare spending, North America emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Bioactive Glasses Market include SCHOTT AG, Mo-Sci Corporation, Noraker, Vitryxx AG, NovaBone Products LLC, Stryker Corporation, BonAlive Biomaterials Ltd, Zimmer Biomet Holdings Inc., Corning Incorporated, Sinanen Zeomic Co. Ltd., Arthrex Inc., DePuy Synthes (Johnson & Johnson), Biomet 3i LLC, Dentsply Sirona Inc., Mitsubishi Chemical Corporation, and Matexcel.

Key Developments:

In Sep 2025, SCHOTT AG introduced bioactive glass granules with a customized strontium and zinc ion release profile, designed to significantly enhance osteoblast activity and accelerate bone regeneration in spinal fusion procedures.

In Aug 2025, Mo-Sci Corporation launched its PerioGlas(R) Shield, a new injectable putty for periodontal bone defects that provides a physical barrier and sustained release of silicate ions to promote periodontal ligament attachment and alveolar bone repair.

In July 2025, Stryker Corporation announced the launch of NovaBone(R) Dental Putty with Silver, a first-to-market formulation that combines the osteoconductive properties of bioactive glass with the antimicrobial efficacy of silver ions for infected dental extraction sites.

Types Covered:

  • Silicate-Based Bioactive Glasses
  • Borate-Based Bioactive Glasses
  • Phosphate-Based Bioactive Glasses
  • Other Types

Forms Covered:

  • Powders
  • Fibers
  • Granules

Technologies Covered:

  • Melt Quenching
  • Sol-Gel Process
  • Flame Synthesis
  • Other Technologies

Applications Covered:

  • Bone Regeneration
  • Dental Care
  • Orthopedic Implants & Coatings
  • Wound Healing
  • Drug Delivery

End Users Covered:

  • Hospitals & Clinics
  • Dental Clinics
  • Research Institutes
  • Medical Device Manufacturers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Glasses Market, By Type

  • 5.1 Introduction
  • 5.2 Silicate-Based Bioactive Glasses
  • 5.3 Borate-Based Bioactive Glasses
  • 5.4 Phosphate-Based Bioactive Glasses
  • 5.5 Other Types

6 Global Bioactive Glasses Market, By Form

  • 6.1 Introduction
  • 6.2 Powders
  • 6.3 Fibers
  • 6.4 Granules

7 Global Bioactive Glasses Market, By Technology

  • 7.1 Introduction
  • 7.2 Melt Quenching
  • 7.3 Sol-Gel Process
  • 7.4 Flame Synthesis
  • 7.5 Other Technologies

8 Global Bioactive Glasses Market, By Application

  • 8.1 Introduction
  • 8.2 Bone Regeneration
  • 8.3 Dental Care
  • 8.4 Orthopedic Implants & Coatings
  • 8.5 Wound Healing
  • 8.6 Drug Delivery

9 Global Bioactive Glasses Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Dental Clinics
  • 9.4 Research Institutes
  • 9.5 Medical Device Manufacturers

10 Global Bioactive Glasses Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 SCHOTT AG
  • 12.2 Mo-Sci Corporation
  • 12.3 Noraker
  • 12.4 Vitryxx AG
  • 12.5 NovaBone Products LLC
  • 12.6 Stryker Corporation
  • 12.7 BonAlive Biomaterials Ltd
  • 12.8 Zimmer Biomet Holdings Inc.
  • 12.9 Corning Incorporated
  • 12.10 Sinanen Zeomic Co. Ltd.
  • 12.11 Arthrex Inc.
  • 12.12 DePuy Synthes (Johnson & Johnson)
  • 12.13 Biomet 3i LLC
  • 12.14 Dentsply Sirona Inc.
  • 12.15 Mitsubishi Chemical Corporation
  • 12.16 Matexcel

List of Tables

  • Table 1 Global Bioactive Glasses Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Glasses Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Bioactive Glasses Market Outlook, By Silicate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 4 Global Bioactive Glasses Market Outlook, By Borate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 5 Global Bioactive Glasses Market Outlook, By Phosphate-Based Bioactive Glasses (2024-2032) ($MN)
  • Table 6 Global Bioactive Glasses Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 7 Global Bioactive Glasses Market Outlook, By Form (2024-2032) ($MN)
  • Table 8 Global Bioactive Glasses Market Outlook, By Powders (2024-2032) ($MN)
  • Table 9 Global Bioactive Glasses Market Outlook, By Fibers (2024-2032) ($MN)
  • Table 10 Global Bioactive Glasses Market Outlook, By Granules (2024-2032) ($MN)
  • Table 11 Global Bioactive Glasses Market Outlook, By Technology (2024-2032) ($MN)
  • Table 12 Global Bioactive Glasses Market Outlook, By Melt Quenching (2024-2032) ($MN)
  • Table 13 Global Bioactive Glasses Market Outlook, By Sol-Gel Process (2024-2032) ($MN)
  • Table 14 Global Bioactive Glasses Market Outlook, By Flame Synthesis (2024-2032) ($MN)
  • Table 15 Global Bioactive Glasses Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 16 Global Bioactive Glasses Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Bioactive Glasses Market Outlook, By Bone Regeneration (2024-2032) ($MN)
  • Table 18 Global Bioactive Glasses Market Outlook, By Dental Care (2024-2032) ($MN)
  • Table 19 Global Bioactive Glasses Market Outlook, By Orthopedic Implants & Coatings (2024-2032) ($MN)
  • Table 20 Global Bioactive Glasses Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 21 Global Bioactive Glasses Market Outlook, By Drug Delivery (2024-2032) ($MN)
  • Table 22 Global Bioactive Glasses Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Bioactive Glasses Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 24 Global Bioactive Glasses Market Outlook, By Dental Clinics (2024-2032) ($MN)
  • Table 25 Global Bioactive Glasses Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 26 Global Bioactive Glasses Market Outlook, By Medical Device Manufacturers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.